AHA Statement on Court Ruling Halting 2022 340B Drug Pricing Program Cuts

Melinda Hatton
General Counsel and Secretary
American Hospital Association

September 28, 2022

The AHA appreciates Judge Contreras’ ruling that the Department of Health and Human Services must immediately stop unlawful reimbursement cuts for 2022 for hospitals participating in the 340B drug pricing program. Halting these cuts will help 340B hospitals provide comprehensive health services to their patients and communities.

Earlier this year, the U.S. Supreme Court declared HHS’ 340B cuts for 2018 and 2019 were unlawful, but had not ruled on 2020 or afterward. We continue to urge the Administration to promptly reimburse all the hospitals that were affected by these unlawful cuts in previous years and to ensure the remainder of the hospital field is not penalized for their prior unlawful policy, especially as hospitals and health systems continue to deal with rising costs for supplies, equipment, drugs and labor.

###

Contact:    Colin Milligan, cmilligan@aha.org
                  Sean Barry, sbarry@aha.org